Almac

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

07-Sep-2022 By Nick Taylor

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

Pharma execs talk trends in Almac Group survey

16-Nov-2020 By Jenni Spinner

The company’s annual survey of pharmaceutical and biotechnology leaders reveals their needs, plans and concerns for the immediate and long-term future.

Almac: How to build a solid clinical trial supply chain

22-Jul-2020 By Jenni Spinner

An industry expert from the global CDMO offers advice on how to plan for a successful clinical trial supply chain, and avoid mistakes along the way.

Almac supports COVID-19 studies in Africa

22-Jun-2020 By Jenni Spinner

The CDMO has landed a grant from the Bill and Melinda Gates Foundation’s COVID-19 Therapeutics Accelerator for clinical research in the sub-Saharan region.

Almac IRT solution designed to speed startup

09-Jun-2020 By Jenni Spinner

The company’s Simplify technology is designed to help sponsors and CROs reduce the time required to launch a clinical trial.

Almac Discovery collaborates with Merck on DUB targets

30-Apr-2020 By Jenni Spinner

The partnership will focus on generating novel small-molecule inhibitors against specific DUB targets for treatment of a range of diseases.

Almac lands GMP certification for Irish site

25-Feb-2020 By Vassia Barba

Following an inspection at its Ireland site, Almac received compliance certification for its Almac Adapt Just in Time’ clinical packaging and labelling manufacturing services.

Almac, Pfizer reveal steps to slash gene therapy labeling times

12-Feb-2020 By Nick Taylor

Almac outlines work with Pfizer to quickly get patient-specific gene therapies to DMD patients.

Almac launches digital labeling service for clinical products

11-Feb-2020 By Vassia Barba

Aiming to assist developers in managing ‘a range of labeling scenarios’, Almac brings a digital label approval system to market.

Almac granted $1m to develop low-cost API manufacturing method

09-Dec-2019 By Vassia Barba

Under funding from Bill and Melinda Gates Foundation, Almac initiates work to develop biosynthetic routes for APIs to be used in world aid programs.

Inceptua and Bendalis partner on 'Brexit-safe' clinical trial supply service

04-Dec-2019 By Nick Taylor

Inceptua Group and Bendalis join forces to supply generic cancer drugs for use in clinical trials.

Almac joins clinical supply blockchain working group

24-Sep-2019 By Vassia Barba

Almac joins a working group made up of clinical supply chain industry members, in order to contribute to the use case discussion about blockchain technology.

Minimizing risks and maximizing outcomes in sample management

14-Aug-2019 By Melissa Fassbender

Almac bolsters its global clinical trial supply management and logistics offering – a market predicted to reach $26bn by 2024, according to a recent report.

Update

Almac launches site storage temperature module

29-Apr-2019 By Melissa Fassbender

TempEZ is a web-based temperature data management software providing a single secure database to collect temperature data from clinical sites.

Almac expanding personalized cancer vaccine production facilities

21-Jan-2019 By Melissa Fassbender

The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.

Almac expands neo-antigen peptide manufacturing

02-Jan-2019 By Maggie Lynch

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.

How to secure the clinical supply chain in the face of a natural disaster

13-Nov-2018 By Melissa Fassbender

To manage the supply chain challenges faced by natural disasters, experts say to expect the unexpected – ensuring a strong shipping strategy is in place with temperature control and robust management.

Almac to offer GMP peptide manufacturing services for cancer vaccines

07-Aug-2018 By Melissa Fassbender

Almac Group will commence GMP supply of neoantigen-derived peptides for use in individualized cancer vaccine production later this year.

Almac acquires BioClin as analytical services business grows

06-Nov-2017 By Melissa Fassbender

Almac Group’s acquisition of BioClin Laboratories expands the company’s analytical services – a growing area of business due to increasing global client requirements, says CDMO.

Almac to collaborate with Exostar on cloud-based management solutions

15-Dec-2016 By Melissa Fassbender

Almac Clinical Technologies, part of the Almac Group, has announced a collaboration with Exostar to help mitigate risk associated with intellectual property.

Almac to hire 180 at ex-AZ site in UK

09-Nov-2015 By Fiona BARRY

CDMO Almac says it will hire 180 people following a £16m ($24m) expansion of formulation and analytical services.

Almac buys biocatalysis partner Arran, expanding capacity and services

04-Nov-2015 By Dan Stanton

Almac has acquired Arran Chemical Company to further grow its biocatalysis services and increase its large-scale intermediates capacity.

Patient-centric model driving pharma service sector interest in DTP trial drug delivery

18-Sep-2015 By Gareth Macdonald

More evidence of sponsor demand for direct-to-patient (DTP) services with Marken announcing an expansion of its deal with GlobalCare Clinical Trials just a week after rival Almac launched its to-the-door study drug delivery offering in Europe.

Almac announces $7m biocatalysis partnership

02-Feb-2015 By Fiona BARRY

Contract development and manufacturing organisation (CDMO) Almac has invested $7m (€5.5m) in a biocatalysis R&D partnership with Queens University Belfast.

Almac announces Government backed recruitment drive

14-Aug-2014 By Gareth Macdonald

Northern Ireland-based contractor Almac will create 348 jobs over the next five years in its pharma and clinical services business according to UK enterprise, trade and investment Minister, Arlene Foster.

Almac Diagnostics Expands Biomarker Biz With Illumina Tech

11-Sep-2013

Almac Diagnostics has launched a new cancer tumour profiling services that will use Illumina’s next-generation sequencing (NGS) TruSight Tumor panel.

Almac Expands Capacity and Workforce with £13.7m Double Expansion

12-Jun-2013 By Dan Stanton

Investment in Almac’s Northern Ireland plant will keep production costs competitive with low-cost economies, according to the company.

FDA approves packaging plant as Almac welcomes US clients

06-Feb-2013 By Dan Stanton

Almac says that FDA approval of its commercial packaging plant will open doors to fulfill demand from the US market.

KTP adds string to Almac’s biocatalysis bow

22-Jan-2013 By Dan Stanton

Almac says the completion of a Knowledge Transfer Partnership (KTP) has aided biocatalysis development offering clients an array of streamlined processes.

Almac opens new non-GMP plant and says 'send us your CV!'

16-Jan-2013 By Dan Stanton

Almac Group says high demand for potent tabs and liquids was driving forces in creation of its new $10.5 million facilities.

Almac and Quintiles latest to invest in genomics for personalised meds

21-Aug-2012 By Gareth Macdonald

Genomic analysis seems to be an area of interest for the contract services sector at the moment with Northern Ireland-based Almac and US CRO Quintiles only the latest firms to make investments in the field.

Almac launches on-site QP consultation service

14-Jun-2012 By Gareth Macdonald

Almac has come up with a variation on the QP consulting business with a new service that provides on-site oversight.

Almac invests $10m in US packaging site

12-Mar-2012 By Gareth Macdonald

Almac says high-speed lines at its newly expanded US contract packaging facility will help it be cost competitive.

Almac to expand pharmaceutical development services with new Craigavon facility

27-Oct-2011 By Alexandria Pesic

Almac is to expand its pharmaceutical development services with the creation of a new facility at its headquarters in Craigavon, Northern Ireland.

Almac to add HPAPI capacity to retain customers’ projects into late phase development

24-Oct-2011 By Gareth Macdonald

Almac hopes adding high potency API manufacturing capacity at its plant in Craigavon, Northern Ireland will help it retain early phase projects as they move to late-stage development.

update

Almac and Greenphire team on automated trial patient payment

06-Oct-2011 By Gareth Macdonald

Almac Clinical Technologies has teamed up with Greenphire to create an integrated payment system for study patients that encourages participation.

Almac co-invests in cold storage capacity with US client

28-Mar-2011 By Gareth Macdonald

Almac Pharma Services has expanded its cold storage capacity for biopharmaceuticals, continuing the contract manufacturing organisation’s (CMO) busy expansion programme.

Almac partners with Exco InTouch on trial patIent management

21-Mar-2011 By Gareth Macdonald

Contract services firm Almac aims to expand its trial patient management and compliance offering though a new partnership with ePRO specialist Exco InTouch.

Almac adds language-based pack unit for niche and orphan drugs

25-Nov-2010

Almac says new late-stage customisation suite at its facility will cater for firms wishing to launch orphan and niche drugs in Europe.

North American HQ to facilitate growth, says Almac

20-Sep-2010 By Gareth Macdonald

In an exclusive Q&A Mark Rohlfing, Almac’s director of Quality, updates Outsourcing-pharma on the firm’s new North American HQ, growth plans and US recruitment drive.

Multiple appointments at Almac and a new chairman at TranScrip Partners – People on the move

16-Nov-2009 By Nick Taylor

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including multiple appointments at Almac and a new chairman at TranScrip Partners.

Almac unveils Portadown expansion plan

28-Sep-2009 By Gareth Macdonald

Northern Ireland-based contract services firm Almac has been cleared to expand its HQ in Portadown, creating up to 500 new jobs.

Almac automates pre-trial validation with HP’s help

14-Apr-2009 By Gareth Macdonald

Almac claims it can bring drugs to trial faster using an automated approach to compliance that cuts the time taken to validate manufacturing processes by several months.

Almac offers US innovators integrated solid state services

03-Feb-2009 By Gareth Macdonald

Almac Sciences, part of global contracting group Almac, chose this year’s Informex in San Francisco, US to showcase its solid state chemistry (SSC) services to drugmakers in North America.

MHRA OK for Almac’s Durham distribution center.

11-Dec-2008 By Gareth Macdonald

The MHRA has renewed its approval of Almac’s facility in North Carolina, bringing an end to a busy and successful four months of inspections at the clinical services group’s facilities.

Solid state chemistry rounds out Almac Sciences

07-Oct-2008 By Phil Taylor

Almac Sciences of Northern Ireland has introduced a new business unit covering solid state chemistry in a move that addresses a missing link in its technology portfolio.